US equities |
SPCX $175.08 ▲+2.33% NVDA $242.41 ▲+1.47% MU $1,064.90 ▲+0.09% MRVL $296.40 ▲+9.27% AMD $640.98 ▲+1.46% SNDK $1,681.29 ▼-1.34% TSLA $379.61 ▲+0.23% META $737.73 ▼-0.56%
FinancialContent

Articles published by Alpine Immune Sciences Inc.

News headline image
Alpine Immune Sciences Announces Participation in September Investor Conferences
From Alpine Immune Sciences Inc.
Via Business Wire
Tickers ALPN
News headline image
Just – Evotec Biologics and Alpine Immune Sciences Expand Partnership for Commercial Process Development of ALPN-303
From Alpine Immune Sciences Inc.
Via Business Wire
Tickers ALPN EVO
News headline image
Alpine Immune Sciences Appoints Jörn Drappa, MD, PhD, to Board of Directors
From Alpine Immune Sciences Inc.
Via Business Wire
Tickers ALPN
News headline image
Alpine Immune Sciences Announces Update on ALPN-303, a Dual BAFF/APRIL Inhibitor for Systemic Lupus Erythematosus and Other Autoimmune and Inflammatory Diseases, at EULAR 2022
From Alpine Immune Sciences Inc.
Via Business Wire
Tickers ALPN
News headline image
AACR 2022: Davoceticept (ALPN-202) Monotherapy Reduces Tumors, Supports Multiple Expansion Cohorts
From Alpine Immune Sciences Inc.
Via Business Wire
Tickers ALPN
News headline image
Alpine Immune Sciences Announces Company Presentation and Update on AACR Investor Event
From Alpine Immune Sciences Inc.
Via Business Wire
Tickers ALPN